Department of Physical Medicine & Rehabilitation, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Sociology and Aging Studies Institute, Maxwell School of Citizenship and Public Affairs, Syracuse University, Syracuse, NY, 13244, USA.
Disabil Health J. 2020 Jul;13(3):100942. doi: 10.1016/j.dhjo.2020.100942. Epub 2020 May 24.
Despite possibly higher risk of severe outcomes from COVID-19 among people with intellectual and developmental disabilities (IDD), there has been limited reporting of COVID-19 trends for this population.
To compare COVID-19 trends among people with and without IDD, overall and stratified by age.
Data from the TriNetX COVID-19 Research Network platform was used to identify COVID-19 patients. Analysis focused on trends in comorbidities, number of cases, number of deaths, and case-fatality rate among patients with and without IDD who had a positive diagnosis for COVID-19 through May 14, 2020.
People with IDD had higher prevalence of specific comorbidities associated with poorer COVID-19 outcomes. Distinct age-related differences in COVID-19 trends were present among those with IDD, with a higher concentration of COVID-19 cases at younger ages. In addition, while the overall case-fatality rate was similar for those with IDD (5.1%) and without IDD (5.4%), these rates differed by age: ages ≤17 - IDD 1.6%, without IDD <0.01%; ages 18-74 - IDD 4.5%, without IDD 2.7%; ages ≥75- IDD 21.1%, without IDD, 20.7%.
Though of concern for all individuals, COVID-19 appears to present a greater risk to people with IDD, especially at younger ages. Future research should seek to document COVID-19 trends among people with IDD, with particular attention to age related trends.
尽管智障和发育障碍患者(IDD)感染 COVID-19 后出现严重后果的风险可能更高,但针对这一人群的 COVID-19 趋势报告有限。
比较 IDD 患者和非 IDD 患者的 COVID-19 趋势,总体上和按年龄分层。
使用 TriNetX COVID-19 研究网络平台的数据来识别 COVID-19 患者。分析重点是在 2020 年 5 月 14 日之前,COVID-19 诊断呈阳性的 IDD 和非 IDD 患者的合并症、病例数、死亡数和病死率趋势。
ID 患者存在与 COVID-19 结局较差相关的特定合并症的患病率较高。在 IDD 患者中,COVID-19 趋势存在明显的年龄相关差异,年龄较小的患者 COVID-19 病例更为集中。此外,尽管 IDD(5.1%)和非 IDD(5.4%)患者的总体病死率相似,但这些比率因年龄而异:年龄≤17- IDD 1.6%,非 IDD <0.01%;年龄 18-74- IDD 4.5%,非 IDD 2.7%;年龄≥75- IDD 21.1%,非 IDD 20.7%。
尽管 COVID-19 对所有人都构成关注,但它似乎对 IDD 患者构成更大的风险,尤其是在年龄较小的患者中。未来的研究应致力于记录 IDD 患者的 COVID-19 趋势,特别关注与年龄相关的趋势。